与风湿性心脏病和严重肺高血压共存的肺气膜微病:一个病例报告
Aadithya Shyllesh H1, Tehsim A Memon2, Pranathi Guruswamy1
1Internal Medicine, Ramaiah Medical College Hospital, Ramaiah University of Applied Sciences, Bengaluru, IND.
这一案例突出了一个罕见的肺膜微病 (PAM) 与风湿性心脏病 (RHD) 并存的例子. 在复杂的心肺病例中,早期识别双重病理对于管理严重肺高血压至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
背景情况:
- 肺膜微病 (PAM) 是一种罕见的肺部疾病,导致酸的积累.
- 风湿性心脏病 (RHD) 可以导致严重的肺高血压.
- PAM和RHD的同时存在是非常罕见的.
研究的目的:
- 报告一个患有PAM和RHD的患者的独特病例.
- 在这种情况下,强调严重肺高血压的诊断挑战.
- 突出考虑双重病理的重要性.
主要方法:
- 一个63岁的男性患有渐进性呼吸障碍的病例报告.
- 肺高血压的临床评估.
- 诊断调查包括胸部成像,支气管支气管洗和对SLC34A2突变的基因检测.
主要成果:
- 确认了PAM的诊断,具有特征性的"沙尘暴"化.
- 确定了SLC34A2基因突变.
- 被诊断为同时存在的类风湿性心肌狭窄症和严重的肺高血压,归因于PAM和RHD.
结论:
- PAM和RHD的双重病理会导致严重的肺高血压.
- 心脏病患者的新呼吸道症状需要广泛的差异诊断,而不仅仅是心脏病原因.
- 早期识别PAM对于管理至关重要,即使与RHD.同时存在.
更多相关视频
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
相关概念视频
Rheumatic Heart Disease I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
